CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group, Inc. (NYSE MKT:XXII), a leader in tobacco harm reduction R&D and product development, announced today that the Company will make presentations at both the 2015 Marcum MicroCap Conference in New York City and the 5th Annual LD Micro Invitational in Los Angeles.
2015 Marcum MicroCap Conference
|Location: Grand Hyatt, 109 East 42nd St, New York, NY 10017|
|Date: May 27-28, 2015|
5th Annual LD Micro Invitational
|Location: Luxe Sunset Blvd Hotel, 11461 Sunset Blvd, Los Angeles, CA 90049|
|Date: June 1-3, 2015|
Both by-invitation-only investor conferences focus on promising, undervalued companies in the micro-cap space. Henry Sicignano III, President and Chief Executive Officer of 22nd Century Group, will deliver a formal presentation at each conference and will provide a business overview, highlights, and updates on the Company. In addition, Mr. Sicignano will be available for one-on-one meetings at each conference.
To arrange a one-on-one meeting with 22nd Century, please contact Andrew Haag at email@example.com or 1-866-976-4784.
About 22nd Century Group, Inc.
22nd Century Group is a plant biotechnology company focused on technology which allows it to increase or decrease the level of nicotine in tobacco plants through genetic engineering and plant breeding. The Company’s mission is to reduce the harm caused by smoking. 22nd Century owns or exclusively controls 128 issued patents and 52 pending patent applications in 96 countries. The Company’s strong IP position led to a licensing agreement with British American Tobacco (“BAT”), the world’s second largest tobacco company. Visit www.xxiicentury.com for more information.